IZMYND8-34
Gecertificeerd

IZMYND8-34

Catalog #: HY-403538-01
Maat: 5 mg

Kwaliteit

ISO Gecertificeerd

Levering

24-48 uur

Prijs -1%
Login voor prijs
BTW niet inbegrepen
Gratis verzending vanaf €100

Technische Specificaties

Description

IZMYND8-34 is a histone reader ZMYND8 inhibitor that inhibits ZMYND8's histone recognition. iZMYND8-34 can be used for the research of neuroendocrine prostate cancer[1].

CAS Number

1358901-59-3

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

Zinc Finger Protein

Related Pathways

Cell Cycle/DNA Damage

Applications

Cancer-programmed cell death

Field of Research

Cancer

Purity

98.89

Solubility

DMSO : 10 mg/mL (ultrasonic)

Smiles

O=C(C1=C2N(C)C(N(C3=CC=C(OCO4)C4=C3)C2=NC(C5=CC=CC(OCC)=C5O)=N1)=O)N

Molecular Formula

C22H19N5O6

Molecular Weight

449.42

Precautions

H302, H315, H319, H335

References & Citations

[1]Wang H, et, al. Targeting the histone reader ZMYND8 inhibits antiandrogen-induced neuroendocrine tumor transdifferentiation of prostate cancer. Nat Cancer. 2025 Apr;6 (4) :629-646.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Product MSDS

http://file.medchemexpress.com/batch_PDF/HY-403538/iZMYND8-34-SDS-MedChemExpress.pdf

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Beschrijving

IZMYND8-34 is a histone reader ZMYND8 inhibitor that inhibits ZMYND8's histone recognition. iZMYND8-34 can be used for the research of neuroendocrine prostate c

Specificaties

ProductnaamIZMYND8-34
Categorie
Beschikbare grootte5 mg
CatalogusnummerHY-403538-01